Michael H. Cardone
0009-0001-0356-7681
Publication & Citation Trends
Most Cited Works
Publications
88 total
Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs
Cited by 1
Semantic Scholar
Correction: Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications OA
Cited by 0
Semantic Scholar
Abstract A024: Assessing Mitondiral Priming in Leukemia Using BH3 Complex Specific Antibodies (PRIMABS): Prediciting Patient Response to Apoptosis Inducing Drugs
Cited by 0
Semantic Scholar
Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications PDF
Cited by 35
OpenAlex
BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in myeloid malignancies PDF
Cited by 194
OpenAlex
Mcl-1 Mediates TWEAK/Fn14-Induced Non–Small Cell Lung Cancer Survival and Therapeutic Response PDF
Cited by 43
OpenAlex
Hydroxyquinoline-derived compounds and analoguing of selective Mcl-1 inhibitors using a functional biomarker PDF
Cited by 55
OpenAlex
Research Topics
Cancer Mechanisms and Therapy
(19)
NF-κB Signaling Pathways
(14)
Cell death mechanisms and regulation
(13)
Acute Myeloid Leukemia Research
(13)
Protein Degradation and Inhibitors
(10)
Frequent Co-Authors
Affiliations
Translational Genomics Research Institute
The University of Texas MD Anderson Cancer Center
Cancer Treatment Centers of America
University of California, San Francisco
Sanford Burnham Prebys Medical Discovery Institute